ResearcherIstituto PasteurActive in the last 2 years
Francesco Spallotta
Matched on ORCID iD 0000-0002-0466-6286; OpenAlex author ID A5091896958. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 17
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic can… Last author DOI 10.1038/s41419-026-08475-w↗
- The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration. Last author DOI 10.1186/s13046-024-03263-w↗
- Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with a… Co-author DOI 10.1136/jitc-2021-002876↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Silvia Malatesta · 2 shared papers, 2025–2026 · strength 0.43
- Paper α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process inc… DOI 10.1038/s41419-026-08475-w↗
- Paper The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylatio… DOI 10.1186/s13046-024-03263-w↗
- Chiara Cencioni · 2 shared papers, 2025–2026 · strength 0.43
- Paper α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process inc… DOI 10.1038/s41419-026-08475-w↗
- Paper The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylatio… DOI 10.1186/s13046-024-03263-w↗
- Vincenzo Corbo · 2 shared papers, 2021–2025 · strength 0.31
- Paper The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylatio… DOI 10.1186/s13046-024-03263-w↗
- Paper Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative … DOI 10.1136/jitc-2021-002876↗
- Antonio Agostini · 2 shared papers, 2021–2025 · strength 0.31
- Paper The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylatio… DOI 10.1186/s13046-024-03263-w↗
- Paper Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative … DOI 10.1136/jitc-2021-002876↗
- Geny Piro · 2 shared papers, 2021–2025 · strength 0.31
- Paper The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylatio… DOI 10.1186/s13046-024-03263-w↗
- Paper Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative … DOI 10.1136/jitc-2021-002876↗
- Giampaolo Tortora · 2 shared papers, 2021–2025 · strength 0.31
- Paper The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylatio… DOI 10.1186/s13046-024-03263-w↗
- Paper Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative … DOI 10.1136/jitc-2021-002876↗
- Carmine Carbone · 2 shared papers, 2021–2025 · strength 0.31
- Paper The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylatio… DOI 10.1186/s13046-024-03263-w↗
- Paper Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative … DOI 10.1136/jitc-2021-002876↗
- Gian Luca Rampioni Vinciguerra · 1 shared paper, 2026 · strength 0.22
- Giulia Piaggio · 1 shared paper, 2026 · strength 0.22
- Gianni Colotti · 1 shared paper, 2026 · strength 0.22
- Danilo Ranieri · 1 shared paper, 2025 · strength 0.20
- Alberto Larghi · 1 shared paper, 2025 · strength 0.20
- Paola Cappello · 1 shared paper, 2021 · strength 0.11
- Francesco De Sanctis · 1 shared paper, 2021 · strength 0.11
- Pietro Delfino · 1 shared paper, 2021 · strength 0.11
- Claudio Sette · 1 shared paper, 2021 · strength 0.11
- Aldo Scarpa · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.